Abstract
Clinicogenetic and pathological studies have shown that mutations of the glucocerebrosidase gene (GBA) are a risk factor for Parkinson's disease and Lewy body disorders. In the present study, we have identified GBA mutations in 6.8% (4/59) of cases with a pathological diagnosis of diffuse Lewy body disease. Taken with previous studies, it appears that GBA mutations are associated with a more diffuse pattern of Lewy body distribution involving the cerebral cortex than the brainstem/limbic distribution observed in typical Parkinson's disease.
| Original language | English |
|---|---|
| Pages (from-to) | 55-57 |
| Number of pages | 3 |
| Journal | Parkinsonism and Related Disorders |
| Volume | 17 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2011 |
| Externally published | Yes |
ASJC Scopus Subject Areas
- Neurology
- Geriatrics and Gerontology
- Clinical Neurology
Keywords
- DLBD
- Gaucher disease
- GBA
- Genetics
Fingerprint
Dive into the research topics of 'Glucocerebrosidase mutations in diffuse Lewy body disease'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS